Tiazac Capsule, Extended Release
Product Images NDC 0187-2617

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tiazac (NDC 0187-2617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Label for TIAZAC 120 mg extended-release capsules containing diltiazem hydrochloride. The label states this is a prescription drug, with 30 capsules per bottle, produced by Bausch Health US, LLC. It includes NDC 0187-2612-30 and storage and usage information.*

FDA Label Image

Image 02

Label for TIAZAC extended-release capsules, USP, 180 mg, containing diltiazem hydrochloride. The label shows the prescription drug designation, a package size of 30 capsules, and indicates the product is distributed by Bausch Health US, LLC. It includes a barcode and usage instructions about seal integrity and storage.*

FDA Label Image

Image 03

TIAZAC extended-release capsules 240 mg, containing diltiazem hydrochloride, presented in a bottle label for 30 capsules. The label shows the NDC 0187-2614-30 and is distributed by Bausch Health US, LLC. It includes usage instructions and storage information, emphasizing not to use if the bottle closure seal is broken.*

FDA Label Image

Image 04

Label for TIAZAC EXTENDED RELEASE 300 mg capsules containing diltiazem hydrochloride. This extended-release oral capsule packaging by Bausch Health US, LLC includes 30 capsules. The label features dosage strength, NDC 0187-2615-30, and warnings such as not using if the bottle closure seal is broken.*

FDA Label Image

Image 05

TIAZAC Extended-Release Capsules, USP 420 mg, diltiazem hydrochloride, oral capsule, extended release dosage form. The label shows the product name and strength prominently, with the dosage form and quantity of 30 capsules. The labeler is Bausch Health US, LLC. The label includes a barcode and prescription-only designation.*

FDA Label Image

Image 06

TIAZAC extended-release capsules, USP 360 mg oral capsules by Bausch Health US, LLC. The label shows NDC 0187-2616-30 and indicates the product contains 30 capsules. It includes usage caution to not use if the bottle closure seal is broken and additional storage and handling information.*

FDA Label Image

Chemical Structure (Tiazac 01)

Chemical structure of diltiazem hydrochloride showing its molecular components and arrangement including the benzothiazepine ring system and substituent groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.